These results provide the first evidence of functional TRPV3 expression in bladder cancer cells and suggest that TRPV3 may contribute to Ca<sup>2+</sup>- and cholesterol-dependent signaling pathways. The gene discussed is TRPV3; the disease is urinary bladder carcinoma.